We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Handheld COVID-19 Disinfecting Wand Kills 99.9% of SARS-CoV-2 in 10 Seconds

By HospiMedica International staff writers
Posted on 10 Dec 2020
A new handheld disinfecting wand against SARS-CoV-2 (COVID-19) has passed validation testing by achieving a confirmed >99.97% level of disinfection in 10 seconds.

The Acuva SOLARIX handheld disinfecting wand against SARS-CoV-2 developed by Acuva Technologies Inc. (Burnaby, BC, Canada) is a portable and rechargeable UV-LED disinfection device that fits in the pocket. It delivers powerful chemical-free disinfection performance which achieves an efficacy rate of >99.9% against viruses and bacteria, including all coronaviruses. Using the SOLARIX device, users can safely disinfect high-touch non-porous surfaces. Featuring high-intensity germicidal UV energy, the device is designed for efficacy, portability, safety and ease of use. Its battery charges with a common USB-C cable so users can easily connect it to any USB port to recharge.

Image: The Acuva™ SOLARIX handheld disinfecting wand (Photo courtesy of Acuva Technologies Inc.)
Image: The Acuva™ SOLARIX handheld disinfecting wand (Photo courtesy of Acuva Technologies Inc.)

The SOLARIX includes a number of features to ensure safe operation, including visible blue light mapping to indicate the area being disinfected. It opens to a wide 270-degree angle to allow for faster and easier disinfection of contoured and difficult to reach surfaces, in comparison to typical sanitizing practices and cleaning solutions. A built-in sensor prevents any accidental user hand exposure to UV. It also includes a built-in timer and a power button that requires double-click activation as a child-lock function.

"My personal ordeal with COVID-19 earlier this year gave me time to think about others facing this ruthless virus," said Manoj Singh, CEO of Acuva. "We decided to join the fight against COVID-19 by doing what we do best. We applied the same key principles used in our signature approach to UV-LED disinfection system design towards the creation of new products to help mitigate the spread of the virus."

Related Links:
Acuva Technologies Inc.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Monitor Cart
Tryten S5
New
Mobile Power Procedure Chair
LeMans P360

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles